CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities
Net (loss) income	$ (1,324)	$ 1,115
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	4,300	4,307
Amortization of deferred financing costs charged to interest expense	433	457
Stock-based compensation expense	647	193
Deferred income taxes, net	(501)	780
Changes in operating assets and liabilities:
Accounts receivable	2,552	(14,421)
Other assets	974	(661)
Accounts payable and accrued liabilities	(4,996)	(6,567)
Accrued payroll	(6,157)	2,275
Other liabilities	(698)	984
Net cash used in operating activities	(4,770)	(11,538)
Investing activities
Purchase of equipment and improvements	(39)	(552)
Net cash used in investing activities	(39)	(552)
Financing activities
Proceeds from revolving line of credit	67,396	59,910
Repayment of revolving line of credit	(62,362)	(47,509)
Payments of deferred financing costs	0	(202)
Payment of tax obligations resulting from net exercise of stock options	(93)	0
Net cash provided by financing activities	4,941	12,199
Net change in cash	132	109
Cash - beginning of period	125	342
Cash - end of period	257	451
Supplemental disclosure of cash flow information
Cash paid during the period for interest	3,003	3,594
Cash paid during the period for income taxes	0	32
Common stock surrendered for the exercise of stock options	(93)	0
Lease liability recognized to acquire a right-of-use asset	$ 0	$ 1,377